Počet záznamov: 1
Dissecting anxiogenic and anxiolytic properties of the CRH/CRHR1- system using genetic mouse models
SYS 0065314 LBL 00000naa^^22^^^^^^^^450 005 20110822163422.3 100 $a 20110629a2011 m y0sloy0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a Dissecting anxiogenic and anxiolytic properties of the CRH/CRHR1- system using genetic mouse models $f D. Refojo ... [et al.] 463 -1
$1 001 sllk_un_cat*0064689 $1 011 $a 1210-0668 $1 200 1 $a Endocrine regulations $v Vol. 45, no. 2 (2011), s. [144] $1 210 $a Bratislava $c AEPress $d 2011 $1 215 $a s. 65-110, (Abstracts A1-A48) 541 1-
$a Rozoberané anxiogénne a anxiolytické vlastnosti CRH/CRHR1- systému pomocou genetického modelu u myši $z slo 606 1-
$3 sllk_un_auth*d013315 $a stres psychologický $2 mesh 606 1-
$3 sllk_un_auth*d018019 $a receptory hormónu uvoľňujúceho kortikotropín $x fyziológia $2 mesh 606 1-
$3 sllk_un_auth*d003346 $a hormón uvoľňujúci kortikotropín $2 mesh 606 2-
$3 sllk_un_auth*d009452 $a neuroendokrinológia $2 mesh 606 2-
$3 sllk_un_auth*d051379 $a myši $9 C $2 mesh 608 $3 sllk_un_auth*d016416 $a abstrakt z kongresu $2 mesh 701 -1
$3 sllk_un_auth*0021442 $a Refojo $b D. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021443 $a Schweizer $b M. $p Affectis Pharmaceuticals, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021444 $a Kuehne $b C. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021445 $a Ehrenberg $b S. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021446 $a Thoeringer $b C. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021447 $a Vogl $b A. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021448 $a Dedic $b N. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021449 $a Schumacher $b M. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021450 $a Von Wolf $b G. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021451 $a Engblom $b D. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021452 $a Schuetz $b G. $p Cancer Research Center, Heidelberg, Germany $4 070 701 -1
$3 sllk_un_auth*0021453 $a Deneris $b E. $p Case Western Reserve University, School of Medicine, Cleveland, USA $4 070 701 -1
$3 sllk_un_auth*0021455 $a Nave $b K.-A. $p Max Planck Institute of Experimental Medicine, Goettingen, Germany $4 070 701 -1
$3 sllk_un_auth*0021457 $a Eder $b M. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021458 $a Wotjak $b C. T. $p Max Planck Institute of Psychiatry, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021459 $a Sillaber $b I. $p Affectis Pharmaceuticals, Munich, Germany $4 070 701 -1
$3 sllk_un_auth*0021460 $a Wurst $b W. $p Helmholtz Zentrum München, Institute of Developmental Genetics, Neuherberg, Germany $4 070 701 -1
$3 sllk_un_auth*p0031049 $a Holsboer $b F. $4 070 701 -1
$3 sllk_un_auth*0021441 $a Deussing $b J. M. $4 070 $p Max Planck Institute of Psychiatry, Munich, Germany 712 12
$3 sllk_un_auth*0021258 $a Symposium on catecholamines and other neurotransmitters in stress $d 10. $e Smolenice, Slovensko $f 2011 801 -0
$a SK $b BA006 $c 20110629 $g AACR2
Počet záznamov: 1